A NAPE-PLD activator
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

VU534

Item No. 39744

Technical Information
Formal Name
N-(5,7-dimethyl-2-benzothiazolyl)-1-[(4-fluorophenyl)sulfonyl]-4-piperidinecarboxamide
CAS Number
923509-20-0
Synonyms
  • N-Acyl-Phosphatidylethanolamine-Hydrolysing Phospholipase D Activator 534
  • NAPE-PLD Activator 534
Molecular Formula
C21H22FN3O3S2
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Soluble: ≥10 mg/mlMethanol: Slightly Soluble: 0.1-1 mg/ml
SMILES
CC1=CC(C)=C2C(N=C(NC(C3CCN(S(=O)(C4=CC=C(F)C=C4)=O)CC3)=O)S2)=C1
InChi Code
InChI=1S/C21H22FN3O3S2/c1-13-11-14(2)19-18(12-13)23-21(29-19)24-20(26)15-7-9-25(10-8-15)30(27,28)17-5-3-16(22)4-6-17/h3-6,11-12,15H,7-10H2,1-2H3,(H,23,24,26)
InChi Key
RLHUIVPGYWWIQZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    VU534 is an activator of N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD), which hydrolyzes NAPEs into N-acyl ethanolamines (NAEs) and phosphatidic acid.1 It increases NAPE-PLD activity in cell-free assays (EC50s = 0.3 and 0.93 µM for the recombinant mouse and human enzymes, respectively). VU534 (20 µM) also increases NAPE-PLD activity in RAW 264.7 cells, an effect that can be blocked by the NAPE-PLD inhibitor bithionol (Item No. 21844), and in HepG2 cells (EC50 = 1.5 µM). It also inhibits soluble epoxide hydrolase (sEH) with a maximal inhibition of 55% and weakly inhibits fatty acid amide hydrolase (FAAH). VU534 (10 µM) increases efferocytosis in isolated wild-type mouse bone marrow-derived macrophages (BMDMs) but not in BMDMs isolated from Napepld-/- mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zarrow, J.E., Alli-Oluwafuyi, A.M., Youwakim, C.M., et alSmall Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages. ACS Chem. Biol. 18(8), 1891-1904 (2023).